ReWalk 7 is made by Lifeward, based in Yokneam, Israel, founded in 2001.

Where is ReWalk 7 deployed?

No verified deployments of ReWalk 7 are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.

What is ReWalk 7's maturity stage?

ReWalk 7 is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Robot model

ReWalk 7

Name: ReWalk 7
Brand: Lifeward

Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.

ReWalk 7 is an exoskeleton robot built by Lifeward.

Track ReWalk 7Email on verified state changes. Cap-flags flow through.

Machine-readable surfaces

Markdown mirror: /models/rewalk-7.md
JSON-LD: embedded in this page’s head
REST API: /v1/models/2f847d21-9b21-4ce0-bb03-6d2bd97ae10b
Revision history: /models/rewalk-7/history
Data documentation: /data
Query this programmatically: Deploy MCP

Form factor: exoskeleton
Maturity stage: commercial
Lifecycle: active
Deployments: 0
ID: 2f847d21-9b21-4ce0-bb03-6d2bd97ae10b

Deploy Watch

Track ReWalk 7 on Deploy.

We notify you when pricing, deployment status, or regulatory state changes against primary-source evidence, not when the maker issues claims.

Specs

use: medical (personal, SCI)
control: weight-shift triggered powered gait
powered: yes (motor-driven)
regulatory: FDA cleared 2025-03
body_region: lower-limb
availability: commercial (2025 launch)

Manufacturer-attributed media (1)

Manufacturer-supplied media at the model level. Not tied to an independently verified named-site deployment. Verification posture is product-showcase from the maker, distinct from the deployment-verified evidence in the section above.

PRIMARY SOURCE

Courtesy of Lifeward

Lifeward's footage of a user navigating stairs and curbs in the current-generation ReWalk personal exoskeleton (ReWalk 7). Stepping is triggered by tilt sensors and the user's forward body-weight shift, with crutches for balance: worn and user-controlled, not autonomous. FDA-cleared for spinal-cord injury home and community use.

Sources (2)

Common questions

What is ReWalk 7?: Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
Who makes ReWalk 7?: ReWalk 7 is made by Lifeward, based in Yokneam, Israel, founded in 2001.
Where is ReWalk 7 deployed?: No verified deployments of ReWalk 7 are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
What is ReWalk 7's maturity stage?: ReWalk 7 is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-06-06

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-06-06

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1: primary-company-ir; Company IR disclosure
1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.